Published: February 2016
Report Code: LS10603
Category : Healthcare
The U.S. scar treatment market accounted for $4,757.8 million revenue in 2014, and it is expected to grow with a CAGR of 10.2% during 2015-2020. The products segment dominated the U.S. market in 2014 with about 59.4% share; whereas, among the various therapies, the dermabrasion segment accounted for the highest share of 25.6% in the U.S. scar treatment market in the same year. The U.S. scar treatment market is witnessing high growth rate due to growing cases of skin problems leading to scar formation, availability of technologically advanced products that have the capability to fade away the scars, and increasing appearance consciousness among consumers. Also, the increasing expenditure on personal care is further propelling the growth of the market.
Acne is a dermatological condition, which is caused due to the clogging of hair follicles by dirt, sebum, and dead skin cells. Acne affects majority of the U.S. population and can lead to scaring. According to the American Academy of Dermatology, approximately 85% of the U.S. population suffers from acne at some phase of their life, which eventually leads to scar formation later. Various other skin problems, such as burns, post-surgical marks, and stretch marks, due to pregnancy or changes in body weight also lead to scar formation. These skin problems can lead to the formation of scars, which do not fade away easily. They need to be treated using scar treatment products and surgical treatments for their removal. Laser treatments and minimally-invasive surgical treatments are more advanced treatments than topical ointments, which help to improve the appearance of scars within few hours to few days. The availability of various products, such as creams, oils, gels and sprays over the counter for treating scar leads to the growth of the market. These products further help in reducing redness, pain, bumps, and itching caused by scars, and can be applied without medical supervision, which is driving the growth of the U.S. scar treatment market.
The product segment grew with an average annual growth rate of over 10.1% during 2011-2014. The scar treatment creams market on the other hand grew with a CAGR of 10.6% during 2011-2014.
The restraints associated with the growth of the U.S. scar treatment market include the side effects of the usage of scar treatment products and therapies. Furthermore, the high cost of scar treatment therapies is hampering the growth of the market.
The key companies operating in the U.S. scar treatment market include MerzPharma, Valeant Pharmaceuticals International Inc., Pacific World Corporation, Oculus Innovative Sciences, Inc. Enaltus, LLC, Johnson & Johnson Services, Inc., CCA Industries Inc., Revitol Corporation Inc., Scarguard Labs LLC, and Quantum Health.